Because GIV coordinates intracellular signaling pathways enabling growth factor–autonomous survival and proliferation of circulating tumor cells (32, 60), we investigated effects of GIV on hematogenous dissemination of ER+ breast cancer cells. Here, ESR1 is linked to breast carcinoma.